Start-up companies working in artificial intelligence scored sizeable increases in venture financing, and were highly prized acquisition targets in 2018, a new analysis shows. . . . → Read More: Venture Funds, Mergers in A.I. Up Sharply in 2018
|
|||||
|
|
A drug that invokes the immune system to block addictive effects of opioid pain drugs and heroin is in early development at Washington University in St. Louis. . . . → Read More: NIH Funding Nanodrugs to Prevent Opioid Addiction 
The Bill and Melinda Gates Foundation is enlisting a company that discovers therapeutic antibodies to help researchers develop new drugs and vaccines for serious infectious diseases. . . . → Read More: Gates Supporting Infectious Antibody Discovery 
A not-for-profit foundation is evaluating a robotic device to help people with spinal cord injuries regain use of their arm, wrist, and hand after a spinal cord injury. . . . → Read More: Foundation Studies Robotic Arm-Wrist Assist Device 
Implantable collections of insulin-producing islet cells resembling tea bags, for people with type 1 diabetes, are being developed by researchers at University of Arizona. . . . → Read More: Univ. Developing Implanted Islet Cell Bags for Diabetes 
A spin-off enterprise from University of Delaware is developing an electronic vibrating device that fits on the feet or ankles of people with Parkinson’s disease to help them walk. . . . → Read More: Fox Foundation Supports Parkinson’s Walking Device  One comment - (Comments are closed)  Finance, New products  biomedical, clinical trials, engineering, entrepreneurs, grant, licensing, life sciences, medical device, NSF, physical sciences, software, university 
A company developing treatments for inherited eye diseases that replace malfunctioning with healthy genes is being acquired by biotechnology company Biogen. . . . → Read More: Biogen Acquires Gene Therapy Company in $800M Deal Comments are closed Finance biomedical, biotechnology, clinical trials, entrepreneurs, equity, genomics, investment, life sciences, merger, pharmaceuticals, U.K., university 
Spark Therapeutics, a biotechnology company that pioneered gene therapies, is being acquired by drug maker Roche Group in a deal valued at $4.3 billion. . . . → Read More: Gene Therapy Company Acquired in $4.3B Deal One comment - (Comments are closed) Finance biomedical, biotechnology, equity, FDA, genomics, investment, life sciences, merger, pharmaceuticals, university 
A new biotechnology enterprise developing personalized treatments that harness the immune system to treat cancer is raising $10.5 million in its first venture funding round. . . . → Read More: Start-Up Raises $10.5M for Precision Immunotherapies One comment - (Comments are closed) Finance, Intellectual property biomedical, biotechnology, cancer, entrepreneurs, equity, investment, licensing, life sciences, pharmaceuticals, preclinical, venture capital 
A watch-like device is being designed to monitor for early onset of respiratory diseases like the flu, well before noticeable symptoms develop. . . . → Read More: Smart Watch in Development for Respiratory Diseases One comment - (Comments are closed) Finance, New products biomedical, engineering, entrepreneurs, grant, health care, Israel, life sciences, mathematics, medical device, physical sciences, software, university |
||||
|
Copyright © 2019 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||